Description
Researchers at the University of Maryland School of Medicine (UMSOM) became the first in the United States to begin testing experimental COVID-19 vaccine candidates developed by Pfizer and BioNTech. The research, funded by Pfizer Inc., will study the safety, efficacy, and dosing of an experimental mRNA-based vaccine. Included are a news release and video describing the research.Keyword
Coronavirus Disease 2019 (COVID-19)University of Maryland, Baltimore. School of Medicine
COVID-19 (Disease)
RNA, Messenger--therapeutic use
Vaccines
COVID-19